http://orcid.org/0000-0003-2818-270X
Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Harrison J Lee, Vivian WL Tsang, Brandon S Chai, Michelle CQ Lin, Andrew Howard, Christopher Uy & Julius O Elefante. (2023) Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review. Journal of Psychoactive Drugs 0:0, pages 1-15.
Read now
Read now
Yotam D. Ginati, Nir Madjar, Joseph Ben-Sheetrit, Shaul Lev-Ran, Abraham Weizman & Gal Shoval. (2022) A Nationwide Study Comparing Mental Health Professionals’ Willingness to Try Hallucinogenic Drugs in Basic Research or Clinical Practice. Journal of Psychoactive Drugs 54:2, pages 177-187.
Read now
Read now
Melissa F. Lavin & Medora W. Barnes. (2020) Normalizing Deviants: Notes on the De-Stigma Trend. Deviant Behavior 41:7, pages 828-840.
Read now
Read now
Rafael L. Lancelotta & Alan K. Davis. (2020) Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects. Journal of Psychoactive Drugs 52:3, pages 273-281.
Read now
Read now
William E. Brandenburg & Karlee J. Ward. (2018) Mushroom poisoning epidemiology in the United States. Mycologia 110:4, pages 637-641.
Read now
Read now
Benjamin J. Malcolm, Martin Polanco & Joseph P. Barsuglia. (2018) Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine. Journal of Psychoactive Drugs 50:3, pages 256-265.
Read now
Read now
Articles from other publishers (39)
Emmanuelle A.D. Schindler, R. Andrew Sewell, Christopher H. Gottschalk, L. Taylor Flynn, Yutong Zhu, Brian P. Pittman, Nicholas V. Cozzi & Deepak C. D'Souza. (2024) Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial. Journal of the Neurological Sciences 460, pages 122993.
Crossref
Crossref
Burton J. TabaacKenneth Shinozuka, Alejandro ArenasBryce D. BeutlerKirsten CherianViviana D. EvansChelsey FasanoOwen S. Muir. (2024) Psychedelic Therapy: A Primer for Primary Care Clinicians—Psilocybin. American Journal of Therapeutics 31:2, pages e121-e132.
Crossref
Crossref
Li Dong, Li Li, Yunlian Wu, Xiaoling Zhao, Hui Zhong, Xi Cheng, Lixia Liu, Changxia Cheng, Mingqiu Ouyang & Liande Tao. (2024) A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases. International Journal of Behavioral Medicine.
Crossref
Crossref
Francis M. Dijkstra, Rob G. J. A. Zuiker, Jules A. A. C. Heuberger, Kawita M. S. Kanhai, Marieke De Kam, Thierry Duvauchelle, Jeanne‐Marie Lecomte, Olivier Labeeuw, Laurent Landais, Xavier Ligneau, Philippe Robert, Marc Capet, Jean‐Charles Schwartz & Joop M. A. van Gerven. (2023) Administration of oxathridine, a first‐in‐class histamine‐3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo‐hallucinations. British Journal of Clinical Pharmacology 90:1, pages 321-335.
Crossref
Crossref
Jeffrey K. Aronson. 2024. Manson's Tropical Diseases. Manson's Tropical Diseases
1136
1160
.
Abigail Calder, Seline Mock, Nicole Friedli, Patrick Pasi & Gregor Hasler. (2023) Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms. European Neuropsychopharmacology 75, pages 1-14.
Crossref
Crossref
Kelan Thomas. (2023) Pharmacists and psychedelic medicine. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 6:10, pages 1082-1083.
Crossref
Crossref
Mitch Earleywine, Maha N. Mian & Joseph A. De Leo. (2023) Expectancies for Subjective and Antidepressant Effects in Psilocybin Users. Journal of Humanistic Psychology.
Crossref
Crossref
Pravesh Sharma, Quang Anh Nguyen, Sadie J Matthews, Erin Carpenter, Douglas B Mathews, Christi A Patten & Christopher J Hammond. (2023) Psilocybin history, action and reaction: A narrative clinical review. Journal of Psychopharmacology 37:9, pages 849-865.
Crossref
Crossref
Carla Soares, Gerardo Gonzalo, João Castelhano & Miguel Castelo-Branco. (2023) The relationship between the default mode network and the theory of mind network as revealed by psychedelics – A meta-analysis. Neuroscience & Biobehavioral Reviews 152, pages 105325.
Crossref
Crossref
Elizabeth A. Cairns, Melissa J. Benson, Miguel A. Bedoya-Pérez, Sara L. Macphail, Adith Mohan, Rhys Cohen, Perminder S. Sachdev & Iain S. McGregor. (2023) Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing. Frontiers in Pharmacology 14.
Crossref
Crossref
Junhong Liu, Yuanyuan Wang, Ke Xia, Jinfeng Wu, Danhao Zheng, Aoling Cai, Haitao Yan & Ruibin Su. (2023) Acute psilocybin increased cortical activities in rats. Frontiers in Neuroscience 17.
Crossref
Crossref
Maria Orozco & Shana Harris. (2022) Psilocybin and the Meaning Response: Exploring the Healing Process in a Retreat Setting in Jamaica. Anthropology of Consciousness 34:1, pages 130-160.
Crossref
Crossref
Md. Mominur Rahman, Sadia Afsana Mim, Md. Rezaul Islam, Nasrin Sultana, Muniruddin Ahmed & Mohammad Amjad Kamal. (2023) Role of G-Proteins and GPCR-Mediated Signalling in Neuropathophysiology. CNS & Neurological Disorders - Drug Targets 22:1, pages 2-5.
Crossref
Crossref
John Whelan & Maya Eichler. (2022) Breaking Ranks: How Medically Released Canadian Military Veteran Men Understand the PTSD Diagnosis. Journal of Veterans Studies 8:3, pages 25-36.
Crossref
Crossref
H. Bottemanne, A. Baldacci, C. Muller, A. Boyreau & A. Claret. (2022) Psychothérapie augmentée par la kétamine (KAP) dans les troubles de l’humeur : mode d’emploi. L'Encéphale 48:3, pages 304-312.
Crossref
Crossref
Aryan Sarparast, Kelan Thomas, Benjamin Malcolm & Christopher S. Stauffer. (2022) Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology 239:6, pages 1945-1976.
Crossref
Crossref
Benjamin Malcolm & Kelan Thomas. (2021) Serotonin toxicity of serotonergic psychedelics. Psychopharmacology 239:6, pages 1881-1891.
Crossref
Crossref
Cindy A. Stein, Andrew Penn, Stephanie Van Hope, Caroline G. Dorsen & Mariavittoria Mangini. (2022) The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice. Journal of Midwifery & Women's Health 67:3, pages 373-383.
Crossref
Crossref
IIana Berlowitz. (2022) Plantes psychotropes, médecines traditionnelles autochtones du Pérou et renaissance
psychédélique. Drogues, santé et société 20:1, pages 90-116.
Crossref
Crossref
Jerome Sarris, Diego Pinzon Rubiano, Kimberley Day, Nicole L. Galvão-Coelho & Daniel Perkins. (2022) Psychedelic medicines for mood disorders: current evidence and clinical considerations. Current Opinion in Psychiatry 35:1, pages 22-29.
Crossref
Crossref
Robin E. Ford, Cameo Lyn West, Alicia McGhee & Rebecca Lyn LaLonde. 2021. International Ethics in Chemistry: Developing Common Values across Cultures. International Ethics in Chemistry: Developing Common Values across Cultures
41
61
.
Bernard J. Borserio, Christopher F. Sharpley, Vicki Bitsika, Kimaya Sarmukadam, Phillip J. Fourie & Linda L. Agnew. (2021) Default mode network activity in depression subtypes. Reviews in the Neurosciences 32:6, pages 597-613.
Crossref
Crossref
Ashley N. Siegel, Shakila Meshkat, Katie Benitah, Orly Lipsitz, Hartej Gill, Leanna M.W. Lui, Kayla M. Teopiz, Roger S. McIntyre & Joshua D. Rosenblat. (2021) Registered clinical studies investigating psychedelic drugs for psychiatric disorders. Journal of Psychiatric Research 139, pages 71-81.
Crossref
Crossref
Lucas Pawlik. (2021) Death risk: Lack of movement: The ignored pandemic of digitalization escalates the COVID-19 crisis. Technoetic Arts 19:1, pages 139-152.
Crossref
Crossref
Henry Lowe, Ngeh Toyang, Blair Steele, Henkel Valentine, Justin Grant, Amza Ali, Wilfred Ngwa & Lorenzo Gordon. (2021) The Therapeutic Potential of Psilocybin. Molecules 26:10, pages 2948.
Crossref
Crossref
Jessica Lochtenberg, Ari Kirshenbaum & Matthew W. Johnson. (2021) Pharmacological assistance for psychotherapy. Emerging Trends in Drugs, Addictions, and Health 1, pages 100017.
Crossref
Crossref
Ilana Berlowitz, Ernesto García Torres, Heinrich Walt, Ursula Wolf, Caroline Maake & Chantal Martin-Soelch. (2020) “Tobacco Is the Chief Medicinal Plant in My Work”: Therapeutic Uses of Tobacco in Peruvian Amazonian Medicine Exemplified by the Work of a Maestro Tabaquero. Frontiers in Pharmacology 11.
Crossref
Crossref
Brian T Anderson, Alicia Danforth, Prof Robert Daroff, Christopher Stauffer, Eve Ekman, Gabrielle Agin-Liebes, Alexander Trope, Matthew Tyler Boden, Prof James Dilley, Jennifer Mitchell & Joshua Woolley. (2020) Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. EClinicalMedicine 27, pages 100538.
Crossref
Crossref
Alexander M. Sherwood, Poncho Meisenheimer, Gary Tarpley & Robert B. Kargbo. (2020) An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin. Synthesis 52:05, pages 688-694.
Crossref
Crossref
Bheatrix Bienemann, Nina Stamato Ruschel, Maria Luiza Campos, Marco Aurélio Negreiros & Daniel C. Mograbi. (2020) Self-reported negative outcomes of psilocybin users: A quantitative textual analysis. PLOS ONE 15:2, pages e0229067.
Crossref
Crossref
Candace R. Lewis, Katrin H. Preller, B. Blair Braden, Cory Riecken & Franz X. Vollenweider. (2020) Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience. Biomedicines 8:2, pages 34.
Crossref
Crossref
Chris Fields & James F. Glazebrook. (2020) Scale-free architectures support representational diversity. Behavioral and Brain Sciences 43.
Crossref
Crossref
Christopher B. Germann. (2020) The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging. Medical Hypotheses 134, pages 109406.
Crossref
Crossref
Katie Givens Kime. 2020. Encyclopedia of Psychology and Religion. Encyclopedia of Psychology and Religion
792
796
.
Junchi Zhang, Yang He, Xiangrui Jiang, Hualiang Jiang & Jingshan Shen. (2019) Nature brings new avenues to the therapy of central nervous system diseases—An overview of possible treatments derived from natural products. Science China Life Sciences 62:10, pages 1332-1367.
Crossref
Crossref
Matteo Polit, Fabio Friso & Jacques Mabit. (2019) Plant based assisted therapy for the treatment of substance use disorders part 2 : beyond blurred boundaries.. Cultura y Droga 24:28, pages 19-42.
Crossref
Crossref
Katie Givens Kime. 2018. Encyclopedia of Psychology and Religion. Encyclopedia of Psychology and Religion
1
4
.
M. F. Lazenka & B. A. Hutsell. (2017) Preclinical Models for Assessment of Antidepressant Abuse Potential. Current Sexual Health Reports 9:4, pages 241-250.
Crossref
Crossref